Researchers found that mutations in this gene increased the risk of chronic obstructive pulmonary disease, bone marrow failure, and other conditions.
In counting defective proviruses, approaches for estimating the size of HIV patients' virus reservoirs are throwing off estimates of treatment effectiveness.
Tufts scientists and their colleagues called for steps to ensure that disadvantaged groups benefit from genetically based diagnoses and treatments.
A renal cell carcinoma study revealed increased metabolic gene expression in PD-L1-positive tumors from individuals who did not respond to nivolumab.
Considering the widespread use of the cell line, these findings could have significant implications for the research community.
A clear unmet clinical need coupled with the persuasive study data suggests that it shouldn't be long before this type of testing is made available clinically.
Researchers also uncovered key pathways and alterations linked to differences in survival.
Metabolon will work with Johns Hopkins University and Tufts Medical Center to develop and clinically validate the new blood-based diagnostic.
The Johns Hopkins University-led team developed a model to gauge absolute breast cancer risk based on genetic, other non-modifiable, and modifiable factors.
When molecular testing did affect the surgical plan, it often led to overtreatment, according to the Johns Hopkins University School of Medicine team.
23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.
By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.
NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.
In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.